Comparing Stability and Efficacy of Incobotulinumtoxin A Refrigerated for Two Weeks as Compared With Its Fresh Version: A Nonrandomized Clinical Trial

Dermatol Surg. 2024 Sep 1;50(9):887-889. doi: 10.1097/DSS.0000000000004212. Epub 2024 May 3.

Authors

Bardiya Ghaderi Yazdi¹, Atena Khodabakhsh¹, Pouya B Bastani², Siamak Abdi^{1

3}

Affiliations

¹ Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Neurology, Division of Neuro-Visual & Vestibular Disorders, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Center for Orthopedic Trans-disciplinary Applied Research, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 39196823
DOI: 10.1097/DSS.0000000000004212

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Botulinum Toxins, Type A* / administration & dosage
Drug Stability*
Drug Storage
Female
Humans
Male
Middle Aged
Neuromuscular Agents / administration & dosage
Refrigeration
Treatment Outcome

Substances

Botulinum Toxins, Type A
incobotulinumtoxinA
Neuromuscular Agents